(Reuters) – Sobi North America, the North American unit of Swedish Orphan Biovitrum AB, said on Thursday the U.S. Food and Drug Administration authorized its arthritis drug, Kineret, for treating COVID-19 related pneumonia.
(Reporting by Bhanvi Satija in Bengaluru; Editing by Shinjini Ganguli)
